* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a rise in quarterly revenue when it reports results on
November 3.
* The Alhambra California-based company is expected to
report a
18.7% increase in revenue to $269.594 million from $227.12
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for earnings of 32 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $47.5, above its last closing price of $35.23.
This summary was machine generated November 2 at 02:12 GMT. All
figures in US dollars unless otherwise stated